C07D - Heterocyclic compounds

More topics under "C07D - Heterocyclic compounds" (1,537,440)
C07D 201 - Preparation, separation, purification, or stabilisation of unsubstituted lactams (2,192)
C07D 203 - Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom (1,097)
C07D 205 - Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom (6,868)
C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304)
C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780)
C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939)
C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676)
C07D 217 - Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems (11,865)
C07D 219 - Heterocyclic compounds containing acridine or hydrogenated acridine ring systems (2,120)
C07D 221 - Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups (10,931)
C07D 223 - Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom (8,732)
C07D 225 - Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom (1,649)
C07D 227 - Heterocyclic compounds containing rings having one nitrogen atom as the only ring hetero atom, according to more than one of groups (473)
C07D 229 - Heterocyclic compounds containing rings of less than five members having two nitrogen atoms as the only ring hetero atoms (515)
C07D 231 - Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings (25,550)
C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408)
C07D 235 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings (15,325)
C07D 237 - Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings (8,468)
C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619)
C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings (18,673)
C07D 243 - Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms (5,961)
C07D 245 - Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms (898)
C07D 247 - Heterocyclic compounds containing rings having two nitrogen atoms as the only ring hetero atoms, according to more than one of groups (239)
C07D 249 - Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms (17,749)
C07D 251 - Heterocyclic compounds containing 1,3,5-triazine rings (10,913)
C07D 253 - Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group (2,967)
C07D 255 - Heterocyclic compounds containing rings having three nitrogen atoms as the only ring hetero atoms, not provided for by groups (739)
C07D 257 - Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms (9,612)
C07D 259 - Heterocyclic compounds containing rings having more than four nitrogen atoms as the only ring hetero atoms (488)
C07D 261 - Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings (11,459)
C07D 263 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings (20,978)
C07D 265 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms (11,132)
C07D 267 - Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms (2,022)
C07D 269 - Heterocyclic compounds containing rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms according to more than one of groups (111)
C07D 271 - Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms (7,144)
C07D 273 - Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups (2,368)
C07D 275 - Heterocyclic compounds containing 1, 2-thiazole or hydrogenated 1,2-thiazole rings (4,972)
C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621)
C07D 279 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms (5,149)
C07D 281 - Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms (1,924)
C07D 283 - Heterocyclic compounds containing rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms, according to more than one of groups (102)
C07D 285 - Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups (9,964)
C07D 291 - Heterocyclic compounds containing rings having nitrogen, oxygen and sulfur atoms as the only ring hetero atoms (1,087)
C07D 293 - Heterocyclic compounds containing rings having nitrogen and selenium or nitrogen and tellurium, with or without oxygen or sulfur atoms, as the ring hetero atoms (553)
C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005)
C07D 301 - Preparation of oxiranes (10,136)
C07D 303 - Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom (12,512)
C07D 305 - Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms (5,442)
C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108)
C07D 309 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings (12,815)
C07D 311 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings (24,127)
C07D 313 - Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom (3,580)
C07D 315 - Heterocyclic compounds containing rings having one oxygen atom as the only ring hetero atom according to more than one of groups (1,360)
C07D 317 - Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms (18,224)
C07D 319 - Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms (10,283)
C07D 321 - Heterocyclic compounds containing rings having two oxygen atoms as the only ring hetero atoms, not provided for by groups (2,079)
C07D 323 - Heterocyclic compounds containing more than two oxygen atoms as the only ring hetero atoms (1,581)
C07D 325 - Heterocyclic compounds containing rings having oxygen as the only ring hetero atom according to more than one of groups (168)
C07D 327 - Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms (2,428)
C07D 329 - Heterocyclic compounds containing rings having oxygen and selenium or oxygen and tellurium atoms as the only ring hetero atoms (47)
C07D 331 - Heterocyclic compounds containing rings of less than five members, having one sulfur atom as the only ring hetero atom (456)
C07D 333 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom (32,883)
C07D 335 - Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom (4,725)
C07D 337 - Heterocyclic compounds containing rings of more than six members having one sulfur atom as the only ring hetero atom (875)
C07D 339 - Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms (3,352)
C07D 341 - Heterocyclic compounds containing rings having three or more sulfur atoms as the only ring hetero atoms (281)
C07D 343 - Heterocyclic compounds containing rings having sulfur and selenium or sulfur and tellurium atoms as the only ring hetero atoms (52)
C07D 345 - Heterocyclic compounds containing rings having selenium or tellurium atoms as the only ring hetero atoms (419)
C07D 347 - Heterocyclic compounds containing rings having halogen atoms as ring hetero atoms (38)
C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
C07D 407 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group (11,963)
C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
C07D 411 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms (2,465)
C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
C07D 415 - Heterocyclic compounds containing the thiamine skeleton (90)
C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
C07D 419 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms (1,431)
C07D 421 - Heterocyclic compounds containing two or more hetero rings, at least one ring having selenium, tellurium, or halogen atoms as ring hetero atoms (480)
C07D 451 - Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.02,4] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof (5,273)
C07D 453 - Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids (5,704)
C07D 455 - Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine (2,122)
C07D 457 - Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula: , e.g. lysergic acid (836)
C07D 459 - Heterocyclic compounds containing benz [g] indolo [2, 3-a] quinolizine ring systems, e.g. yohimbine; 16, 18-lactones thereof, e.g. reserpic acid lactone (97)
C07D 461 - Heterocyclic compounds containing indolo [3, 2, 1-d, e] pyrido [3, 2, 1-i, j] [1, 5]-naphthyridine ring systems, e.g. vincamine (286)
C07D 463 - Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula: , e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (613)
C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
C07D 473 - Heterocyclic compounds containing purine ring systems (11,932)
C07D 475 - Heterocyclic compounds containing pteridine ring systems (2,718)
C07D 477 - Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula: , e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (2,484)
C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
C07D 489 - Heterocyclic compounds containing 4ah-8, 9 c- iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: (2,334)
C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726)
C07D 493 - Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system (17,376)
C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms (21,336)
C07D 497 - Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms (1,069)
C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960)
C07D 499 - Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula: , e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (3,448)
C07D 501 - Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula: , e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (7,574)
C07D 503 - Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula: , e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (648)
C07D 505 - Heterocyclic compounds containing 5-oxa-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula: , e.g. oxacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (556)
C07D 507 - Heterocyclic compounds containing a condensed beta-lactam ring system, not provided for by groups , or; Such ring systems being further condensed (161)
C07D 513 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or (15,120)
C07D 515 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups , or (877)
C07D 517 - Heterocyclic compounds containing in the condensed system at least one hetero ring having selenium, tellurium, or halogen atoms as ring hetero atoms (452)
C07D 519 - Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or (11,041)
C07D 521 - Heterocyclic compounds containing unspecified hetero rings (16,203)

Patents for C07D - Heterocyclic compounds (10,420)
03/1992
03/10/1992	CA1297099C Quinazoline compounds and their preparation and use
03/08/1992	WO1992004324A1 Phenolic thioetheramides as 5-lipoxygenase inhibitors
03/08/1992	CA2088503A1 Phenolic thioetheramides as 5-lipoxygenase inhibitors
03/04/1992	CN1015714B Prepn. of 7-amino-3-propenylcephalosporanic acid and esters thereof
03/03/1992	US5093337 Substituted derivatives of 20,21-dinoreburnamenine, their use as medicaments and the pharmaceutical compositions containing them
03/03/1992	CA1296716C N-(2-substituted alkyl)-n'-[(imidazole-4-yl) alkyl] guanidine
02/1992
02/26/1992	CN1058958A Hiv-inhibiting benzeneacetamide derivatives
02/25/1992	WO1992003426A1 Piperazinyl derivatives
02/25/1992	CA2089768A1 Piperazinyl derivatives
02/24/1992	WO1992003425A1 Hypoglycemic hydroxyurea derivatives
02/24/1992	CA2087437A1 Hypoglycemic hydroxyurea derivatives
02/20/1992	WO1992002515A1 (2-imidazolin-2-ylamino) quinoxaline derivatives and methods for using same
02/18/1992	US5089527 Pentamidine solutions
02/18/1992	US5089514 3-coxazolyl [phenyl, chromanyl or benzofuranyl]-2-hydroxypropionic acid derivatives and analogs as hypoglycemic agents
02/18/1992	US5089491 Active against both gram-negative and gram-positive bacteria
02/18/1992	US5089168 Stable ferroelectric liquid crystals
02/18/1992	CA1296005C Inhibition of the 5-lipoxygenase pathway
02/16/1992	CA2049176A1 6-substituted-hexahydrobenz [cd] indoles
02/12/1992	EP0470490A1 Substituted pyrroles
02/12/1992	CN1058592A Process for preparation of cyclic sulfates
02/12/1992	CN1015458B Process for preparing heterocyclic compounds
02/06/1992	WO1992001696A1 Cephalosporins and homologues, preparations and pharmaceutical compositions
02/06/1992	WO1992001695A1 Cephalosporins and homologues, preparations and pharmaceutical compositions
02/06/1992	WO1992001675A2 Substituted bicyclic bis-aryl compounds exhibiting selective leukotriene b4 antagonist activity, their preparation and use in pharmaceutical compositions
02/05/1992	EP0469061A1 Fungicidal oxazolidinones
02/04/1992	CA1295252C Azapropazone prevention of post-ischemic tissue damage
02/02/1992	CA2088499A1 Dynemicin analogs: syntheses, methods of preparation and use
01/1992
01/29/1992	EP0468231A2 Guanidins
01/29/1992	CN1058208A Pharmaceutical compounds
01/28/1992	CA1295072C Microbiocidal compositions comprising an aryl alkanol and a microbiocidalcompound dissolved therein
01/25/1992	CA2087848A1 Substituted bicyclic bis-aryl compounds exhibiting selective leukotriene b4 antagonist activity, their preparation and use in pharmaceutical compositions
01/23/1992	WO1992000952A1 Hiv-inhibiting benzeneacetamide derivatives
01/23/1992	CA2084508A1 Hiv-inhibiting benzeneacetamide derivatives
01/21/1992	CA1294736C Renin inhibitors containing 5-amino-2,5-disubstituted- 4-hydroxypentanoic acid residues
01/21/1992	CA1294621C Process for the preparation of 1-methylamino- quinoline-carboxylic acid derivatives
01/17/1992	CA2046105A1 Rapamycin oximes
01/15/1992	EP0237573B1 Novel benzothiazine derivatives
01/15/1992	CN1057839A Azabenzimidazoles in treatment of asthma, arthritis and related diseases
01/14/1992	CA1294274C Method of treating muscle tension, muscle spasticity and anxiety with 3-aryloxy-azetidinecarboxamides
01/10/1992	WO1992000975A1 Method for preparing cyclic sulphates
01/10/1992	CA2081115A1 Process for the preparation of cyclic sulphates
01/09/1992	WO1992000073A1 R(+)-terazosin
01/06/1992	CA2044636A1 Guanidines
01/02/1992	EP0463162A1 PREPARATION OF 5,6,7-TRINOR-4,8-INTER-m-PHENYLENE PGI 2 DERIVATIVES
01/01/1992	CN1057456A Process for preparation of dialkyl, pyridine-2,3-dicarboxylates and derivatives thereof from dialkyl dichloromaleate
01/01/1992	CN1015262B Process for preparation of beta-lactam antibiotics
01/01/1992	CN1015259B Preparation of perhydrothiazepine derivative
12/1991
12/31/1991	CA1293719C Cephem compounds and processes for preparation thereof
12/27/1991	EP0462696A1 Novel pyrido [2,3-f][1,4] thiazepines and pyrido [3,2-b][1,5] benzothiazepines
12/26/1991	WO1991019700A1 Pharmaceutically active benzoquinazoline compounds
12/25/1991	CN1057260A Anti-viral compounds
12/24/1991	US5075440 Hypotensive, bronchodilator agents
12/23/1991	WO1992000070A1 Piperidyl-substituted indoles
12/18/1991	EP0462009A1 Cephalosporins having in position 3 a propenyl radical substituted by a quaternary ammonium, their process for preparation, their use as medicaments, compositions containing them and intermediates
12/18/1991	EP0461401A1 Process for the preparation of dialkyl, pyridine-2,3-dicarboxylates and derivatives thereof from dialkyl dichloromaleate
12/18/1991	CN1015102B Process for preparation of novel quinaldinamide derivs
12/17/1991	US5073574 Tetrazolyl substituted benzonitriles and anti-tumor use thereof
12/16/1991	CA2044700A1 Cephalosporins contening a quaternary ammomium substituted propenyl radical in third position, their preparation process, their pharmaceutical application, their compositions and the new intermediary obtained
12/16/1991	CA2044553A1 Process for the preparation of dialkyl, pyridine-2, 3-dicarboxylates and derivatives thereof from dialkyl dichloromaleate
12/15/1991	WO1991019714A1 Novel oxazole derivatives, a preparation method therefor and pharmaceutical compositions containing same
12/15/1991	WO1991019702A1 3-aryl-2-hydroxypropionic acid derivatives and analogs as hypoglycemic agents
12/15/1991	CA2084898A1 3-aryl-2-hydroxypropionic acid derivatives and analogs as hypoglycemic agents
12/15/1991	CA2080340A1 Oxazole derivatives, a preparation method therefor and pharmaceutical compositions containing same
12/11/1991	EP0220297B1 Nitrogen-containing heterocycles
12/11/1991	CN1056880A Pyrido (2,3-f) (1,4) thiazepines and pyrido (3,2-b) (1,5) benzothiazepines
12/11/1991	CN1056876A Preparation of substituted piperidines
12/10/1991	US5071979 Antibiotics
12/10/1991	US5071844 5,11-dihydrodibenzo[b,e][1,4]-thiazepines useful as gastro intestinal selective calcium antagonists
12/08/1991	WO1991018897A1 Therapeutic heterocyclic compounds
12/06/1991	WO1991019704A2 Oxa- and thiazolidinedione hypoglycemic and hypocholesterolemic agents
12/06/1991	CA2084195A1 Oxa- and thiazolidinedione hypoglycemic and hypocholesterolemic agents
12/04/1991	EP0459900A1 Process for dyeing of keratinic fibres with 2,4-diamino-1,3-dimethoxybenzene in an acid medium and composition using this process
12/04/1991	EP0459819A2 Pharmacologically active CNS compound
12/04/1991	EP0459536A1 Chromogenic acridinone enzyme substrates
12/04/1991	CN1056693A Pharmachutical compounds
12/04/1991	CN1056686A Improved process for preparation of substituted indolone derivatives
12/04/1991	CN1014990B 5-pyrimidinecarboxamides and treatment of leukemia and tumors therewith
12/03/1991	CA1292746C Preparation of difluoropyridine compounds
12/02/1991	WO1991018899A1 3-amino-2-aryl quinuclidines, process for their preparation and pharmaceutical compositions containing them
12/02/1991	CA2043640A1 Pharmacologically active cns compounds
12/01/1991	WO1991018878A1 Preparation of substituted piperidines
12/01/1991	CA2043673A1 Process for dyeing keratinic fibers with 2,4-dimethoxybenzene-1,3-diamines at acid ph; compositions used therefor
11/1991
11/19/1991	US5066812 Chemical intermediates for bactericides
11/12/1991	CA1292002C Propanol derivatives
11/10/1991	WO1991017163A1 IMIDAZO (4,5-c) PYRIDINES WITH PAF ANTAGONIST ACTIVITY
11/10/1991	CA2080476A1 Azabenzimidazoles in the treatment of asthma, arthritis and related diseases
10/1991
10/31/1991	WO1991016327A1 Antimicrobial quinolonyl lactams
10/31/1991	CA2078444A1 Antimicrobial quinolonyl lactams
10/30/1991	EP0454436A1 Pharmaceutical compounds
10/30/1991	EP0454121A2 Azatetracyclic compounds
10/29/1991	US5061793 2-deoxy-2',2'-difluoro-inosine and 5'O-derivatives
10/25/1991	WO1991016320A1 Derivatives and analogues of 2-deoxy-2,3-didehydro-n-acetyl neuraminic acid and their use as antiviral agents
10/22/1991	US5059605 Methyl 2-(pyridyloxypyrimidinyleneoxyphenylene)-3-methoxypropenoates
10/22/1991	CA1291293C Substituted 7-oxomitosanes
10/22/1991	CA1291143C Hmg-coa reductase inhibitors
10/22/1991	CA1291137C 1,4-dihydropyridines with diphenylpiperidylester group
10/22/1991	CA1291134C Process for preparing 1,5-benzothiazepine derivatives
10/18/1991	WO1991016306A1 An improved process for the preparation of substituted indolone derivatives
10/15/1991	US5057614 Substituted pyrroles
10/15/1991	CA1290748C 3-propenylcephem derivative

1 ... 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 ... 105